Logo-npj

J Nephropharmacol. 2021;10(1): e06. doi: 10.34172/npj.2021.06

Perspective

Lessons of mortality following COVID-19 epidemic in the United States especially in the geriatrics

Majid Daneshfar 1 ORCID, Nahid Dadashzadeh 2 ORCID, Mohammad Ahmadpour 3 ORCID, Hedieh Ragati Haghi 4, Vahid Rahmani 5 ORCID, Mehdi Frouzesh 2 * ORCID, Rohollah Valizadeh 6 ORCID

Cited by CrossRef: 14

1- Mirahmadizadeh A, Rezaei F, Jokari K, Moftakhar L, Hemmati A, Dehghani S, Hassani A, Lotfi M, Jafari A, Ghelichi-Ghojogh M. Correlation between environmental factors and COVID-19 indices: a global level ecological study. Environ Sci Pollut Res. 2022;29(11):16667 [Crossref]
2- Gharebaghi N, Farshid S, Boroofeh B, Nejadrahim R, Mousavi J, Dindarian S, Mohammadi S. Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID‐19 in West Azerbaijan Province. Int J Clinical Practice. 2021;75(6) [Crossref]
3- Ghelichi-Ghojogh M, Khezri R, Rezaei F, Aljalili S, Valizadeh R, Sadighpour T. Health inequality in COVID-19 vaccination coverage. Health Science Monitor. 2023;2(1):10 [Crossref]
4- Gutiérrez-Murillo R, Krieger Grossi P, Kuhl Svoboda W. Navigating the pandemic: A critical perspective on COVID-19 responses in Central America. ELECTRON J GEN MED. 2024;21(3):em586 [Crossref]
5- Lanes T, Ribeiro M, Oliveira D, Junior M, Garcia F, Melo J, Tiguman G. Guías de práctica clínica para el tratamiento de la enfermedad por Covid-19 en Brasil: revisión sistemática. Rev Cuid. 2021;12(2) [Crossref]
6- Hassanzadeh S, Sadeghi S, Mirdamadi A, Nematollahi A. Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID‐19 vaccination: A case report. Clinical Case Reports. 2022;10(4) [Crossref]
7- Sadeghi S, Kalantari Y, Shokri S, Fallahpour M, Nafissi N, Goodarzi A, Valizadeh R. Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis. Journal of Clinical Virology. 2022;153:105196 [Crossref]
8- Atefi N, Goodarzi A, Riahi T, Khodabandehloo N, Talebi Taher M, Najar Nobari N, Seirafianpour F, Mahdi Z, Baghestani A, Valizadeh R. Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial. Immunity Inflam & Disease. 2023;11(11) [Crossref]
9- Ebrahimi H, Atashzadeh Shoorideh F, Reza Sohrabi M, Ebrahimi M, Hosseini M. An Analysis of Approaches to Reduction of HIV Stigma across the World through educational interventions: A Scoping Review. Invest Educ Enferm. 2024;42(1) [Crossref]
10- Sadeghmoghadam L, Daneshfar M, Sharifi F, Alizad V. How the first cases of COVID-19 in 10 countries become infected? A case series. Respiratory Medicine Case Reports. 2023;46:101219 [Crossref]
11- Nematshahi M, Soroosh D, Neamatshahi M, Attarian F, Rahimi F. Factors predicting readmission in patients with COVID-19. BMC Res Notes. 2021;14(1) [Crossref]
12- Hajebi A, Rasoulian M, Fathi M, Tiyuri A, Abbasinejad M, Naserbakht M, Asadi A, Khademoreza N. Randomized controlled trial for the efficacy of three versus five sessions of grief counseling on the psychological aspects following COVID-19 bereavement: A study protocol. Front Psychiatry. 2022;13 [Crossref]
13- Kouchek M, Miri M, Aghakhani K, Memarian A. ABO blood group is related to the prevalence, severity, and mortality rate of COVID-19. Medicina Clínica Práctica. 2024;7(3):100442 [Crossref]